Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029835 · ClinicalTrials.gov registry record · Phase 3
Obese Patients With Untreated Dyslipidemias
A Phase 3 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,033
- Enrollment target
NCT00029835: Completed Phase 3 study, sponsored by Sanofi.
NCT00029835 is a Phase 3 study that has completed, run by Sanofi. The registered enrollment target is 1,033 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029835, a Phase 3 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,033 participants
- Enrollment target
Study Summary
To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
Interventions
- DRUG Rimonabant (SR141716)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,033 participants |
| Start Date | 2001-09 |
| Est. Completion | 2003-11 |
| Phase | Phase 3 |
What the finished NCT00029835 record still lists
NCT00029835 is an interventional study that assigns participants to a tested intervention. Its 1,033 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% higher).
The record links to 0 conditions, and to 1 intervention - of which Rimonabant (SR141716) is the first listed.
NCT00029835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00029835 about?
NCT00029835 is a clinical study titled "Obese Patients With Untreated Dyslipidemias". To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
What is the current status of trial NCT00029835?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,033 participants. The study started on 2001-09. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00029835?
The interventions under investigation include: Rimonabant (SR141716) (DRUG).
Who is sponsoring clinical trial NCT00029835?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00029835's enrollment target sits among peer trials
1,033 288th of 2000 higher than 1,713 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia